SKAN Group AG (SWX:SKAN)
Switzerland · Delayed Price · Currency is CHF 65.20
-0.10 (-0.15%)
Aug 24, 2026, 5:31 PM CET
SKAN Group AG Revenue
SKAN Group AG had revenue of 169.77M CHF in the half year ending June 30, 2026, with 1.60% growth. This brings the company's revenue in the last twelve months to 367.38M, up 13.85% year-over-year. In the year 2025, SKAN Group AG had annual revenue of 334.25M, down -5.35%.
Revenue (ttm)
367.38M
Revenue Growth
+13.85%
P/S Ratio
4.04
Revenue / Employee
214.43K
Employees
1,737
Market Cap
1.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 334.25M | -18.89M | -5.35% |
| Dec 31, 2024 | 353.14M | 25.40M | 7.75% |
| Dec 31, 2023 | 327.74M | 46.47M | 16.52% |
| Dec 31, 2022 | 281.27M | 43.11M | 18.10% |
| Dec 31, 2021 | 238.16M | 44.17M | 22.77% |
| Dec 31, 2020 | 193.99M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.96B |
| Novartis AG | 45.81B |
| Lonza Group AG | 6.87B |
| Galderma Group AG | 4.79B |
| Aevis Victoria | 1.04B |
| Tecan Group AG | 870.53M |
| Medacta Group | 636.66M |
| PolyPeptide Group AG | 423.58M |
SKAN Group AG News
- 6 days ago - SKAN Group AG Earnings Call Transcript: H1 2026 - Transcripts
- 6 days ago - SKAN Group AG Slides: H1 2026 - Filings
- 6 days ago - SKAN Group AG Quarterly report: H1 2026 - Filings
- 5 months ago - SKAN Group AG Earnings Call Transcript: H2 2025 - Transcripts
- 5 months ago - SKAN Group AG Annual report: H2 2025 - Filings
- 5 months ago - SKAN Group AG Slides: H2 2025 - Filings